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Epicardial fatAbstract Background: Obesity is an important risk factor for atrial ﬁbrillation (AF). Local epi-
cardial fat enclosed by the visceral pericardial sac has been hypothesized to exert local pathogenic
effects on cardiac structures. We aimed to characterize the relationship between total epicardial fat
volume assessed by noncontrast cardiac CT and AF.
Methods: This case control study conducted from May 2013 to December 2014 in cardiology and
radiology departments of Benha University Hospitals. Fifty patients with a history of AF were
taken up plus control group of 50 reference patients without history of AF. All patients underwent
cardiac CT imaging to measure total epicardial fat volume (EFV), together with systemic obesity
indices as body mass index (BMI), waist circumference and body weight plus echocardiographic
parameters as left atrium (LA) volume index, left ventricular ejection fraction. All these were exam-
ined in relation to the presence and chronicity of AF.
Results: EFV was signiﬁcantly associated with the presence of AF (p values < 0.05). Signiﬁcant
positive correlation between EFV and AF chronicity was denoted. Patients with persistent AF
had signiﬁcantly larger EFV versus patients with paroxysmal AF (p value = 0.002). EFV was pos-
itively correlated with LA volume index (r=+0.45, p< 0.001). Multivariate logistic regression
model for AF risk factors revealed that EFV was the strongest independent risk factor for AF with
highest odds ratio (2.13, 95% CI: 1.01–3.06) followed by odds ratio (1.81, 1.55 and 0.8) for LA vol-
ume index, waist circumference and BMI respectively.
Conclusion: Epicardial fat is associated with the presence of AF and predicts chronicity. These
associations are independent to systemic measures of adiposity and sensitive echocardiographic
parameters as LA volume index. These ﬁndings are consistent with the hypothesis of a local patho-
genic effect of epicardial fat on the arrhythmogenic substrate supporting AF.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of
Cardiology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Atrial ﬁbrillation (AF) is the most common arrhythmia found
in clinical practice.1 It also accounts for 1/3 of hospital admis-
sions for cardiac rhythm disturbances.2 Systemic obesity is a
common modiﬁable risk factor for different cardiovascular
disorders including AF. Above and beyond hazardous effect
of obesity, Epicardial fat deﬁned as the local visceral fat depot
enclosed by the visceral pericardial sac shares the same blood
supply as adjacent myocardium and also shows paracrine
functions. This is the risky fat that is metabolically active
and has been hypothesized to exert a local pathogenic inﬂam-
matory effect on nearby cardiac structures.3 In recent years,
several studies have shown that an increased epicardial fat vol-
ume noninvasively measured by CT or MRI images was
strongly associated with the presence of coronary artery dis-
ease and atrial ﬁbrillation, and adverse cardiovascular events.4
Because multiple factors are related to epicardial fat, we
hypothesized whether epicardial fat could be independently
associated with AF after adjusting multiple factors potentially
related to epicardial fat. Therefore, this study was conducted
to assess the relationship between epicardial fat volume and
the presence and progression of AF when considering covari-
ables related to epicardial fat.
2. Materials and methods
2.1. Study population
This study was a case control study conducted from May
2013 to December 2014 in cardiology and radiology depart-
ments in Benha University Hospitals. One hundred patients
were selected from cardiology department in Benha Univer-
sity Hospital. Their age ranged from 45 to 65 years and
their body mass index (BMI) ranged from 25 to 32. They
were divided into two groups as follows: AF group
included 50 patients with a documented history of AF.
Control group included 50 patients with intermediate risk
and had no history of AF. They had age and sex matching
to AF group.
All patients in both groups were referred for non-contrast
CT for the evaluation of the volume of the total epicardial
fat (EFV). This study was approved by the ethical committee
in the faculty of medicine, Benha University.2.2. Methods
All patients were subjected to the following:
2.2.1. History taking
Age, sex, smoking, hypertension, diabetes mellitus, thyrotoxi-
cosis and documented history of AF.
2.2.2. Anthropometric measurements
Weight in kilograms, height in meters, waist circumference and
body mass index (BMI) ranged from 25 to 32.
2.2.3. Clinical examination
Full general and local cardiac examination.2.2.4. Echocardiography
Transthoracic echocardiography was performed with a com-
mercially available system (Vivid Seven, General Electric, Mil-
waukee, WI). Left atrial volume was calculated using the
modiﬁed biplane Simpson’s method from the apical 2-
chamber and 4-chamber views. (Fig. 1) LA volume index
was calculated from LA volume (ml)/BSA (m2). Left atrial
enlargement was deﬁned as LA volume index >22 + 6
(ml/m2) for both men and women. Left ventricular ejection
fraction (LVEF) was measured using the Simpson method.
An LVEF< 50% was considered abnormal. Structural heart
disease was deﬁned as moderate or greater amount of valvular
regurgitation or left ventricular hypertrophy.5
2.2.5. Noncontrast CT
2.2.5.1. Imaging technique. All CT scans were performed in CT
unit in Benha University Hospital with The Activion 16 multi-
slice CT scanner, Toshiba Medical Systems. The computer
software (Quantum De-noising for Activion 16) was used.
All images were interpreted by a single radiologist who had
more than 15 years of experience in the interpretation of CT
scanning ﬁeld and he was blinded to the history of AF. Tomo-
gram was taken from tracheal bifurcation to the diaphragm in
a single breath-hold in the cranio-caudal direction. The supe-
rior heart limit slice is typically chosen at the split of the pul-
monary artery. The anatomic landmark for the inferior limit
of the heart is typically the most inferior slice of the myocar-
dium or the most inferior slice with the posterior descending
artery.6 Image reconstruction was performed using retrospec-
tive ECG-gated acquisition spiral mode. Since epicardial fat
is a compressible structure, end systolic frames are used to
avoid suspected attenuation of fat during diastole by myocar-
dial mass. A 3-D workstation was used to reconstruct axial
images retrospectively at an optimal window. The image data
sets were analyzed by means of multiplanar reformatted
images (vertical, long-axis, and short-axis views).6
2.2.5.2. Measurement of epicardial fat volume (EFV). Using
the 3.0-mm-thick axial slices the parietal pericardium was
manually traced in every fourth slice starting from the bifurca-
tion of pulmonary artery to the diaphragm. The computer
software (Activion 16) then automatically interpolated and
traced the parietal pericardium in all slices interposed between
the manually traced slices to measure the EFV in cm3. The
total number of slices was 30–40 per heart. All automatically
traced slices were examined and veriﬁed for accuracy. To
ensure adequate ECG gated images and minimal motion arti-
fact, patients in AF received beta-blockers and have CT scan-
ning only if the heart rate controlled to less than 65%. The
typical processing time for this method is 7–10 min. Standard
fat attenuation values are used to deﬁne fat attenuation by
CT; for non-contrast CT typically an attenuation range of
(–30, –190) Hounsﬁeld Units is used. Fat voxels within this
attenuation range within the visceral pericardium are classiﬁed
as epicardial fat, and within the inner thoracic cavity classiﬁed
as thoracic fat (Fig. 2).7
2.3. Statistical analysis of the collected data
Results were collected, tabulated, and statistically analyzed
using statistical Package of Social Science (SPSS) version 11
Figure 1 Left atrial volume was calculated using the modiﬁed biplane Simpson’s method.
Figure 2 Measuring EFV using 3.0-mm-thick axial slices. Case no. 8: male, 56 y, weight = 97 kg, waist = 105.59 cm, BMI = 32.13,
hypertensive and diabetic with persistent AF. (A) Cutoff at level of slice no. 24. (B) Manual tracing of parietal pericardium. (C) Measuring
epicardial fat with exclusion of paracardiac fat using software analysis (EFV = 196.29 cm3) for this case.
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Two main statistical methods were used to present data as
follows:
Descriptive statistics: in which quantitative data were pre-
sented in the form of mean (x), standard deviation and range,
and qualitative data were presented in the form of number and
percentage (%).
Analytical (inferential) statistics: used to ﬁnd out the possi-
ble association between many factors and the targeted disease.
The following statistical tests were applied.
Chi-Squared test (v2), Fischer exact test, t-test, and Mann–
Whitney test.
Correlation: Correlation is a statistical technique that can
show whether and how strongly pairs of variables are related.
Binary logistic regression: A statistical measure that
attempts to determine the strength of the relationship between
one dependent variable (usually denoted by Y) and a series of
other changing variables (known as independent variables).
P-value of <0.05 was considered statistically signiﬁcant.
3. Results
3.1. Patient characteristics
There was age and sex matching between AF and control
groups (P value = 0.15). Mean age equals 58.56 ± 8.79 and
55.80 ± 7.13 for AF and control groups respectively.As regards clinical history, rate of DM and thyrotoxicosis
was signiﬁcantly higher (P value = 0.03 & 0.01) among the
AF group. Hypertension and smoking showed no signiﬁcant
differences in both groups (p value > 0.05). As regards sys-
temic obesity indices, AF group were of signiﬁcantly larger
weight, BMI and waist circumference (P value = 0.038, 0.01
and 0.001) respectively.
As regards different echocardiographic parameters, AF
group showed signiﬁcantly larger LA volume indices and LA
diameters (P value < 0.001). The results showed insigniﬁcant
difference in both studied groups as regards LVEF% and Lt.
ventricular thickness (P value = 0.2 & 0.59).
3.2. Relation between EFV and different parameters
The AF group had a signiﬁcantly larger EFV than the control
group (170.34 ± 44.58 cm3 versus 107.28 ± 40.08 cm3,
p< 0.001) (Table 1). EFV was positively correlated with body
weight (r= 0.25, p= 0.08), BMI (r= 0.38, p= 0.007), and
LA volume index (r= 0.39, P= 0.005). There were no corre-
lations between EFV and weight (r= 0.25, P= 0.08), waist
(r= 0.01, P= 0.95), age, left ventricular ejection fraction,
and left ventricular wall thickness (P> 0.05 for all) (Table 2).
3.3. Multivariate regression model for risk factors of AF
Using Wald test for multiple parameters, this model revealed
that EFV and LA volume index were independent risk factors
Table 1 Comparison of demographic, echocardiographic and CT data in the two groups.
Variable AF group Control group P value
Age 58.56 ± 8.79 55.80 ± 7.13 0.15
Men 35(70%) 33(68%) 0.15
Weight (kg) 89.48 ± 10.94 85.28 ± 8 0.038
BMI 29.21 ± 4.76 27.02 ± 3.60 0.01
Waist circumference (cm) 103.20 ± 7.94 98.10 ± 6.94 0.001
HTN 25% 20% >0.05
DM 20% 6% 0.03
Thyrotoxicosis 12% 0% 0.01
Smoking 30% 25% >0.05
Lt atrial diameter (mm) 43.36 ± 7.11 31.26 ± 6.66 <0.001
X ± SD Range 31–59 20–42
LA volume index (ml/m2) 33.5 ± 6.11 22.56 ± 6.8 <0.001
X ± SD Range 29–36 20–24
LV EF (%) 50.36 ± 8.19 63.32 ± 6.33 0.20
X ± SD range 32–62 54–75
Lt. ventricular thickness (cm) 1.08 ± 0.31 1.03 ± 0.37 0.59
X ± SD range 0.60–1.90 0.60–1.6
Epicardial fat volume (EFV) 170.34 ± 44.58 cm3 107.28 ± 40.08 cm3 <0.001
X ± SD range 90–259 45–211
BMI = body mass index, HTN= hypertension, DM= diabetes mellitus, LA= left atrium, LV = left ventricle, EF: ejection fraction, SD:
standard deviation.
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highest Wald 2 values (10.34 & 11.94) respectively, while
obesity indices as BMI, waist circumference and weight
showed lower odds ratio (0.87, 1.55 & 1.02) and lower Wald
2 values (1.11, 5.6, 0.18 respectively) (Table 3). This data
concluded that EFV by CT and LA volume index by echocar-
diography were the strongest independent risk factors for AF
occurrence.
3.4. Impact of EFV on the progression of AF
66% of the AF group had paroxysmal AF and 34% had per-
sistent AF. There was no signiﬁcant difference between persis-
tent and paroxysmal AF as regards age (P value = 0.34).
There was signiﬁcant association between persistent AF and
male sex as 88.2% of persistent AF subjects were males versus
only 60% among paroxysmal AF cases. Hypertension, DM,
smoking and thyrotoxicosis showed no signiﬁcant differencesTable 2 Correlation between pericardial fat volume and other
parameters among AF group.
Pericardial fat volume (AF group)
Correlation coeﬃcient –
r
P
value
Age 0.32 0.02
Weight/year +0.25 0.08
BMI +0.38 0.007
Waist circumference +0.01 0.95
Left atrial volume index +0.39 0.005
LVEF % +0.16 0.27
Left ventricular wall
thickness
+0.21 0.14
BMI = body mass index, LVEF= left ventricle ejection fraction.among paroxysmal AF and persistent AF cases (P value > 0.05).
Persistent AF group were of signiﬁcantly larger weight and
BMI than paroxysmal AF group (P value < 0.05).
Persistent AF group showed signiﬁcantly larger LA volume
indices than paroxysmal AF group (P value = 0.005). No sig-
niﬁcant difference was seen between two groups as regards
LVEF (%) and Left ventricular thickness (P value > 0.05).
The group with persistent AF had signiﬁcantly larger EFV
than that with paroxysmal AF group (196.29 ± 49.48 cm3 ver-
sus 156.97 ± 35.88 cm3 and P value = 0.002) (Table 4).
4. Discussion
4.1. Major findings
In the current study, detailed echocardiographic and noncon-
trast CT examination was used to present new informationTable 3 Multivariate logistic regression model for risk factors
of AF.
Risk factors Wald
x2
P
value
Odds ratio
(exp. beta)
95% CI
Lower Upper
DM 0.03 0.85 0.88 0.07 9.13
Thyrotoxicosis 0.06 0.81 0.91 0.13 8.70
Weight 0.18 0.67 1.02 0.93 1.12
BMI 1.11 0.29 0.87 0.66 1.13
Waist
circumference
5.65 0.02 1.55 1.02 1.99
Lt. atrial
volume index
11.94 0.001 1.81 1.11 2.45
Epicardial fat
volume
10.34 0.001 2.13 1.01 3.06
Wald x2 =Wald test on multiple parameters, CI = conﬁdence
interval, DM= diabetes mellitus, BMI = body mass index.
Table 4 Comparison between paroxysmal AF subgroup and persistant AF subgroup as regards different risk factors.
Variable Paroxysmal Persistant T test P value
AF AF
N= 33 N= 17
Age (year) 59.42 ± 8.22 56.88 ± 9.85 0.97 0.34
X ± SD range 38–78 40–74
Male 20(60%) 15(88%) 4.02 0.04
HTN 17(51.5%) 8(47.1%) 0.09 0.76
DM 4(12.1%) 6(35.5%) 3.77 0.07
Thyrotoxicosis 5(15.2%) 1(5.9%) 0.91 0.65
Smoking 14(32.4%) 10(58.9%) 1.46 0.48
Weight (kg) 85.51 ± 10.40 97.18 ± 7.38 4.58 <0.001
X ± SD
BMI 26.68 ± 2.99 34.13 ± 3.55 7.82 <0.001
X ± SD
Waist circumference 101.97 ± 6.94 105.59 ± 9.37 1.41 0.17
X ± SD
Lt atrial volume index (ml/m2) 31.39 ± 6.25 37.18 ± 7.28 2.93 0.005
X ± SD
LVEF (%) 50.51 ± 8.72 50.06 ± 7.29 0.18 0.85
X ± SD
Lt. ventricular thickness (cm) 1.10 ± 0.32 1.04 ± 0.29 0.70 0.49
X ± SD
Epicardial fat volume 156.97 ± 35.88 cm3 196.29 ± 49.48 cm3 Mann–Whitney U 0.002
X ± SD 3.23
SD= standard deviation, DM= diabetes mellitus, BMI = body mass index.
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fat depots and AF. The results revealed that, patients with
AF had signiﬁcantly larger EFV compared with control group
(P< 0.001) (Table 1). There was a strong association between
EFV and AF chronicity. Persistent AF patients had a signiﬁ-
cantly larger EFV compared with paroxysmal AF patients
(P= 0.002) (Table 4). These results were in agreement with
those of Al Chekakie et al. who examined the association
between epicardial fat and AF chronicity using noncontrast
CT and demonstrated a signiﬁcant association of EFV with
both paroxysmal and persistent AF. EFV was associated with
both paroxysmal AF (odds ratio 1.11, 95% CI: 1.01–1.23;
p= 0.04) and persistent AF (odds ratio 1.18, 95% CI: 1.05–
1.33; P= 0.004).8 In current study, epicardial fat was strongly
associated with the presence of AF (odds ratio: 2.13; 95% con-
ﬁdence interval: 1.01–3.06, P= 0.04) and this association was
completely independent to DM, thyrotoxicosis, weight, waist
circumference, and BMI (Table 2). Finally, strong positive cor-
relations between EFV and LA volume indices were docu-
mented (r=+0.39, p value = 0.005). While more systemic
measures of adiposity as waist, weight had a lack of same close
positive correlations to EFV (r=+0.01 and +0.25, P
value = 0.95 and 0.08) (Table 2). Our data suggest that epicar-
dial fat may have a pathogenic effect on the anatomically con-
tiguous atria, above and beyond systemic effects of generalized
adiposity. Such effect could promote an arrhythmogenic sub-
strate initiating AF.
4.2. The difference and novelty of the study
In spite of the fact that our results were in agreement with
many previous studies, to our knowledge the present study is
unique in using CT to assess epicardial fat volume plus
echocardiographic measures of LA volume in AF patients.This study provides the ﬁrst report of a clear association
between epicardial fat, LA volume index and AF occurrence.
Previous studies as Thanassoulis et al. who reviewed the Fram-
ingham Heart Study and revealed association between epicar-
dial fat and AF occurrence (P= 0.02) not used the atrial
dimension as a covariate in the multivariable model, while in
the present study we aimed to use LA volume parameters side
by side to different obesity indices in the multivariable model
and showed that EFV and LA volume indices were indepen-
dent risk factors for occurrence of AF.9 Iacobellis et al.10
who tested the relation between epicardial adipose tissue and
atrial dimensions by echocardiography in morbidly obese sub-
jects, found that epicardial fat has been strongly associated
with LA dimensions in AF patients. They had two limitations:
ﬁrst they analyzed epicardial fat thickness using echocardiog-
raphy instead of epicardial fat volume assessed by cardiac
CT which is known to be more accurate measure; second they
used LA volume instead of LA volume index which could limit
the strength of the results and the conclusion obtained from
their study.10
4.3. Hypothesis of a local pathogenic effect of epicardial fat
At a local level, pericardial fat has been associated with
increased expression of numerous inﬂammatory markers.11,12
Intracardiac inﬂammatory markers have also been observed
to be greater than peripheral inﬂammatory markers, and great-
est in the left atrium, which plays a critical role in AF genesis.13
Cytokines have also been shown to activate ﬁbroblasts, with
the extracellular matrix deposition and ﬁbrosis causing elec-
troanatomical remodeling.14 Therefore, the present ﬁnding
supports the notion that epicardial fat may exert deleterious
effects on the anatomically contiguous atria and promote
arrhythmogenesis.
102 M.A. Tabl et al.4.4. Clinical implications
With the increasing use and availability of CT scan, increased
EFV may be used as a risk factor for developing AF or a mar-
ker for AF chronicity.
4.5. Study limitations
The relatively limited number of the patients could limit the
strength of results and conclusion obtained from this study.
5. Conclusion
Epicardial fat is associated with the presence of AF and pre-
dicts chronicity of AF. These associations are both indepen-
dent of systemic measures of adiposity. EFV and LA volume
indices were independent risk factors for occurrence of AF.
Associations between EFV and LA volume changes could
explain the mechanism of AF initiation. These ﬁndings are
consistent with the hypothesis of a local pathogenic effect of
epicardial fat on the arrhythmogenic substrate supporting AF.
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